Carcinoma in situ of skin of left lower limb, including hip
ICD-10 D04.72 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of left lower limb, including hip.
Carcinoma in situ (CIS) of the skin represents a localized, non-invasive form of skin cancer where abnormal cells are present but have not invaded deeper tissues. Specifically, D04.72 refers to CIS located on the skin of the left lower limb, including the hip. This condition is characterized by atypical keratinocytes confined to the epidermis, with no evidence of invasion into the dermis. Commonly associated with sun exposure, CIS can manifest as various lesions, including actinic keratosis or squamous cell carcinoma in situ. Early detection and treatment are crucial to prevent progression to invasive cancer. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy. Regular surveillance is essential to monitor for any changes in the lesions and to manage any potential progression effectively. Patients with a history of skin cancer or significant sun exposure should be particularly vigilant in their follow-up care.
Detailed descriptions of the lesion, including size, type, and treatment plan.
Diagnosis and treatment of skin lesions, follow-up for skin cancer patients.
Ensure accurate mapping of lesions to the correct ICD-10 code based on location and type.
Comprehensive treatment history and follow-up care plans.
Management of patients with a history of skin cancer, including surveillance protocols.
Coordination with dermatology for accurate staging and treatment documentation.
Used when excising a carcinoma in situ lesion.
Document the size and location of the excised lesion.
Dermatology should ensure accurate coding based on the lesion type.
Carcinoma in situ is a localized form of cancer where abnormal cells are present but have not invaded surrounding tissues. It is considered non-invasive and can often be treated effectively.
